Tuesday, February 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

XRP’s Regulatory Milestone Fails to Ignite Price Rally

Robert Sasse by Robert Sasse
December 16, 2025
in Banking & Insurance, Blockchain, Ethereum & Altcoins, Market Commentary
0
XRP Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The XRP token achieved a significant breakthrough in U.S. financial regulation this week, yet its market price continues to struggle. Despite Ripple securing a preliminary national bank charter and witnessing substantial institutional investment, the digital asset trades around $1.98, unable to decisively breach the crucial $2.00 threshold. This divergence between fundamental progress and price action defines the current market sentiment.

Institutional Demand Contrasts with Market Performance

A striking discrepancy is evident in the latest fund flow data. Over the past 20 trading sessions, spot XRP exchange-traded funds (ETFs) have attracted inflows approaching $1 billion. This surge in institutional interest occurred even as major cryptocurrencies like Bitcoin and Ethereum experienced net outflows. Nevertheless, XRP’s value has declined by more than 7% across the last seven days.

Market analysts attribute the persistent price weakness to large-scale investors selling into the institutional ETF demand. This distribution of holdings is suppressing upward momentum despite the strong fundamental backdrop of new capital.

U.S. Regulator Grants Preliminary Bank Charter

On December 15, the Office of the Comptroller of the Currency (OCC) awarded Ripple a provisional license to operate as a national trust bank. This landmark decision subjects the company to oversight as a traditional financial institution for the first time, formally authorizing it to provide custody and settlement services.

The regulatory approval paves the way for Ripple’s proprietary stablecoin, RLUSD, to integrate into the regulated banking framework. Concurrently, the company has expanded RLUSD’s availability to several Ethereum Layer-2 networks, including Base and Optimism. In a separate European development, Switzerland’s AMINA Bank has become the first financial institution to fully integrate Ripple Payments for cross-border transactions.

Should investors sell immediately? Or is it worth buying XRP?

Critical Technical and On-Chain Metrics

Key Market Data Points:

  • The price faces a significant resistance level at $2.03, capping further gains.
  • A critical support zone holds at $1.96, a level that will determine the near-term trend.
  • XRP is currently trading near its 52-week low.
  • A Relative Strength Index (RSI) reading of 28.8 indicates the asset is in oversold territory.
  • Annualized volatility remains elevated at over 54%.

On-chain analysis reveals a notable contraction in available supply. The volume of XRP held on centralized exchanges has plummeted by 45%, from over 3.5 billion tokens to approximately 1.6 billion. While such a reduction in sell-side liquidity is typically considered a bullish indicator, its effect has yet to materialize in price appreciation.

Corporate Deal Highlights XRP’s Valuation Role

Further underscoring institutional engagement, a major corporate transaction was disclosed. VivoPower, through its subsidiary Vivo Federation, is facilitating the acquisition of $300 million worth of Ripple Labs shares for asset manager Lean Ventures. This deal is explicitly linked to roughly 450 million XRP tokens, representing a market value of about $900 million at current prices. The direct correlation between the equity purchase and the cryptocurrency underscores XRP’s central role in the company’s overall valuation.

Broader Market Sentiment Weighs Heavily

The wider digital asset sector is gripped by extreme fear, with the Crypto Fear & Greed Index registering a reading of just 16. Bitcoin trades nearly 30% below its October peak. This overarching macroeconomic uncertainty is currently overshadowing positive individual developments like Ripple’s regulatory progress.

Adding a new dimension to the market, CME Group has initiated trading for spot-based XRP futures, a move that could enhance liquidity between the derivatives and spot markets. The immediate future for XRP appears to hinge on the $1.96 support level. Should this level hold, the combined forces of the bank charter, institutional inflows, and supply contraction may ultimately catalyze a medium-term recovery.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from February 3 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.

XRP: Buy or sell? Read more here...

Tags: XRP
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Commerce Stock
Analysis

Commerce Bancshares Surpasses Market Forecasts in Year-End Report

February 3, 2026
Genworth Stock
Analysis

Strategic Moves at Genworth Financial Ahead of Earnings

February 3, 2026
BancFirst Stock
Analysis

BancFirst Strengthens Regional Footprint with Acquisition Finalization

February 3, 2026
Next Post
Tesla Stock

Tesla's Driverless Taxi Tests Ignite Investor Optimism

Meta Stock

Meta Shares Under Pressure Following Critical Report

Oracle Stock

Oracle Shares Slump as Market Skepticism Overrides AI Partnership Denials

Recommended

iShares MSCI India ETF Stock

India’s Equity Surge: The iShares MSCI India ETF Capitalizes on Economic Momentum

3 months ago
Biotechnology Trading online

Evogene Ltd Reports Record Revenue Growth in 2023 Expands Partnerships and Plans Strategic Shift

2 years ago
Fiserv Stock

Fiserv Shares Under Pressure as Analyst Sentiment Shifts

4 months ago
Eutelsat Stock

Eutelsat’s Strategic Moves Set Stage for Crucial Shareholder Vote

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BancFirst Strengthens Regional Footprint with Acquisition Finalization

iShares MAFE ETF Reaches Fresh 52-Week Peak

PriceSmart Kicks Off Fiscal 2026 with Robust Sales and Expansion Ambitions

Smurfit WestRock’s First Post-Merger Strategy Reveal Approaches

Merger Advances as Gold Resource Corporation Resumes Key Mine Operations

iRobot’s New Chapter: A Private Future After Failed Amazon Deal and Bankruptcy

Trending

SpringWorks Therapeutics Stock
European Markets

Merck KGaA’s Strategic Acquisition of SpringWorks Therapeutics Gains Momentum

by Andreas Sommer
February 3, 2026
0

Six months after finalizing its acquisition, Merck KGaA is hitting significant milestones in its integration of SpringWorks...

Commerce Stock

Commerce Bancshares Surpasses Market Forecasts in Year-End Report

February 3, 2026
Genworth Stock

Strategic Moves at Genworth Financial Ahead of Earnings

February 3, 2026
BancFirst Stock

BancFirst Strengthens Regional Footprint with Acquisition Finalization

February 3, 2026
iShares MSCI EAFE ETF Stock

iShares MAFE ETF Reaches Fresh 52-Week Peak

February 3, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Merck KGaA’s Strategic Acquisition of SpringWorks Therapeutics Gains Momentum
  • Commerce Bancshares Surpasses Market Forecasts in Year-End Report
  • Strategic Moves at Genworth Financial Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com